These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4746586)

  • 1. Slow and rapid inactivators of isoniazid among Greek patients.
    Farhat S; Jodanoglou J; Pallikaris G; Lyberatos K; Gardikas C; Hadjiidannou J
    Am Rev Respir Dis; 1973 Nov; 108(5):1242-3. PubMed ID: 4746586
    [No Abstract]   [Full Text] [Related]  

  • 2. Classification of subjects as slow or rapid inactivators of isoniazid, based on the ratio of the urinary excretion of acetylisoniazid to isoniazid.
    Venkataraman P; Menon NK; Nair NG; Radhakrishna S; Ross C; Tripathy SP
    Tubercle; 1972 Jun; 53(2):84-91. PubMed ID: 5040582
    [No Abstract]   [Full Text] [Related]  

  • 3. Isoniazid-induced acne and pellagra. Occurrence in slow inactivators of isoniazid.
    Cohen LK; George W; Smith R
    Arch Dermatol; 1974 Mar; 109(3):377-81. PubMed ID: 4273616
    [No Abstract]   [Full Text] [Related]  

  • 4. Classification of subjects as slow or rapid inactivators of isoniazid, based on the ratio of the urinary excretion of acetylisoniazid to isoniazid.
    Venkataraman P; Menon NK; Nair NG; Radhakrishna S; Ross C; Tripathy SP
    Indian J Med Res; 1972 May; 60(5):685-93. PubMed ID: 4663236
    [No Abstract]   [Full Text] [Related]  

  • 5. Levels of acetyl hydrazines and rate of acetylation of isoniazid in adult tuberculosis patients.
    Bhalerao EB; Bhide SV
    Indian J Physiol Pharmacol; 1985; 29(2):83-8. PubMed ID: 4093196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoniazid inactivation status and the development of chronic tuberculosis.
    Tiitinen H
    Scand J Respir Dis; 1969; 50(3):227-34. PubMed ID: 5195905
    [No Abstract]   [Full Text] [Related]  

  • 7. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.
    Ylitalo P; Auterinen L; Marttinen A; Koivula T
    Int J Clin Pharmacol Res; 1984; 4(2):141-4. PubMed ID: 6469440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Errors in testing the INH content in the organism].
    Vilenskaia RN
    Probl Tuberk; 1970; 48(11):77-80. PubMed ID: 5516520
    [No Abstract]   [Full Text] [Related]  

  • 9. Simplified isoniazid acetylator phenotyping.
    Russell DW; Eidus L
    Can Med Assoc J; 1972 Jun; 106(11):1155-6. PubMed ID: 5034694
    [No Abstract]   [Full Text] [Related]  

  • 10. [Isoniazid--essential facts and recent advances].
    Zierski M; Rotermund C
    Prax Klin Pneumol; 1984 Jun; 38(6):201-16. PubMed ID: 6382240
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening of isoniazid inactivators by dilution test.
    Hodgkin MM; Eidus L; Hamilton EJ
    Bull World Health Organ; 1974; 51(4):428-30. PubMed ID: 4549494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of insulin on isoniazid and para-aminosalicylic acid metabolism in patients with pulmonary tuberculosis].
    Savula MM; Kiselova ES
    Probl Tuberk; 1974; (8):43-6. PubMed ID: 4409368
    [No Abstract]   [Full Text] [Related]  

  • 13. Isoniazid acetylation rates (phenotypes) of patients being treated for tuberculosis.
    Mason E; Russell DW
    Bull World Health Organ; 1971; 45(5):617-24. PubMed ID: 5316954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate of inactivation of isoniazid in South Indian patients with pulmonary tuberculosis. 2. Clinical implications in the treatment of pulmonary tuberculosis with isoniazid either alone or in combination with PAS.
    SELKON JB; FOX W; GANGADHARAM PR; RAMACHANDRAN K; RAMAKRISHNAN CV; VELU S
    Bull World Health Organ; 1961; 25(6):779-92. PubMed ID: 13910443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentration and urinary excretion of ethambutol administered alone and in combination with isoniazid in patients of pulmonary tuberculosis.
    Singhal KC; Rathi R; Varshney DP; Kishore K
    Indian J Physiol Pharmacol; 1985; 29(4):223-6. PubMed ID: 3842376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative evaluation of rifampicin and isoniazid penetration into the pathological foci of the lungs in tuberculosis patients].
    Kislitsyna NA
    Probl Tuberk; 1985; (4):55-7. PubMed ID: 4001111
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of hyaluronidase on the permeability of the blood-tissue barriers in the complex therapy of patients with pulmonary tuberculosis].
    Khitrina GV; Zakutaeva VP; Tret'iakov AS
    Probl Tuberk; 1971; 49(9):51-5. PubMed ID: 5143430
    [No Abstract]   [Full Text] [Related]  

  • 18. [Concentration and excretion of isoniazid and PAS in patients with tuberculosis depending on the functional status of the kidney].
    Savula MM; Kiselova ES
    Vrach Delo; 1978 May; (5):119-22. PubMed ID: 676253
    [No Abstract]   [Full Text] [Related]  

  • 19. [Distribution and elimination of isoniazid-H3 in pulmonary tuberculosis patients].
    Bondarev IM; Vasil'ev NA; Cherednichenko LP
    Probl Tuberk; 1970; 48(3):65-9. PubMed ID: 5453153
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inactivation of tubazid and its influence on the effectiveness of antibacterial therapy of patients with pulmonary tuberculosis].
    Sumbatov GA; Ioffe RA; Poliakova SG
    Probl Tuberk; 1965; 43(8):23-8. PubMed ID: 5869065
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.